Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress
Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse